Logo

American Heart Association

  30
  0


Final ID:

Lipids, Vascular Inflammation and Gene-editing Therapies on Cardiovascular Disease and Metabolic Disorders

  • Rayner, Katey  ( UNIV OTTAWA HEART INST , Ottawa , Ontario , Canada )
  • Musunuru, Kiran  ( University of Pennsylvania , Philadelphia , Pennsylvania , United States )
  • Zhang, Hanrui  ( COLUMBIA UNIVERSITY MEDICAL CENTER , New York , New York , United States )
  • Author Disclosures:
    Katey Rayner: DO NOT have relevant financial relationships | Kiran Musunuru: DO have relevant financial relationships ; Individual Stocks/Stock Options:Verve Therapeutics:Active (exists now) ; Research Funding (PI or named investigator):Beam Therapeutics:Active (exists now) ; Research Funding (PI or named investigator):Nava Therapeutics:Active (exists now) ; Advisor:Capstan Therapeutics:Active (exists now) ; Advisor:LEXEO Therapeutics:Active (exists now) ; Ownership Interest:Variant Bio:Active (exists now) ; Advisor:Verve Therapeutics:Active (exists now) | Hanrui Zhang: DO NOT have relevant financial relationships
Meeting Info:

Scientific Sessions 2025

2025

New Orleans, Louisiana

Session Info:

Vascular Calcification and Gene-editing Therapy in Peripheral and Cardiovascular Disease

Monday, 11/10/2025 , 01:30PM - 02:45PM

Cardiovascular Seminar

More abstracts on this topic:
Mechanistic Insights into Intimal vs. Medial Calcification via Proteomics

Beach Jocelyn, Martin Kathleen, Turner Mandy, Aikawa Elena

Emerging Discoveries in PAD Pathophysiology and Treatment

Narula Navneet, St. Hilaire Cynthia, Long Xiaochun

You have to be authorized to contact abstract author. Please, Login
Not Available